Apr 29, 2022 9:00am EDT Stevanato Group S.p.A. and Bexson Biomedical, Inc. Expand Collaboration to Treat a Range of Mental Health Conditions With an On-body Device
Apr 27, 2022 7:50am EDT Stevanato Group to Report First Quarter 2022 Financial Results on May 10, 2022
Apr 05, 2022 8:30am EDT Stevanato Group Files Amendment No.1 to Its 2021 Annual Report on Form 20‑F/A
Mar 17, 2022 4:30pm EDT Stevanato Group to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
Mar 01, 2022 8:30am EST Stevanato Group Announces Agreement With BARDA for the Expansion of Vial Production to Create Industrial Base Capabilities for National Defense
Jan 26, 2022 8:00am EST Stevanato Group Extends Pen Injector Technology Licensing Agreement With Haselmeier